Investors & Media

SEC Filing Details

Document Details

Form
Filing Date
Aug 14, 2017
Document Date
Aug 9, 2017
Form Description

Statement of changes in beneficial ownership of securities

Filing Group
3,4,5
Company
bluebird bio, Inc.

Media Contacts

Jenn Snyder

VP, Corporate Communications

(617) 448-0281

JSnyder@bluebirdbio.com

 

Catherine Falcetti

Senior Director, Corporate Communications

(339) 499-9436

CFalcetti@bluebirdbio.com

 

Investor Contact

Elizabeth Pingpank

Director, Corporate Communications

(617) 914-8736

EPingpank@bluebirdbio.com